跳至主要内容
临床试验/EUCTR2018-001466-42-FR
EUCTR2018-001466-42-FR进行中(未招募)1 期

EFFECTIVENESS OF INTRANASAL DEXMEDETOMIDINE FOR SEDATEDAUDITORY BRAINSTEM RESPONSE TESTING - DEXMEDETOMIDINE - ABR

Fondation Lenval - Hôpitaux Pédiatriques de Nice CHULENVA0 个研究点目标入组 60 人开始时间: 2018年4月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Child aged 1 to 15 years old
  • -ASA 1 or 2 (American Society Anesthesiologists scale patient)
  • -Need to evaluate the child audition in a context of suspicion of
  • deafness, delay of language, global delay of the development, the risk
  • factors of hearing loss
  • -Impossibility to realize a hearing test by conventional audiogram or
  • behavioral due to a cognitive or behavioral disorder of the child
  • -Affiliation to social security scheme
  • -Signature of the authorization documents of the 2 parents or the
  • representative of the parental authority for the participation of the child
  • in the study
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Heart disease or heart rhythm disorder
  • - Pneumopathy or asthmatic crisis in previous 2 weeks in the
  • examination
  • - Recent used of digoxine or beta-blocker
  • - Use of anti-epileptic or psychotropic drugs
  • - Medical history of sleep apnea
  • - Receptor alpha2 agonist allergy
  • - Gastrooesophageal reflux disease
  • - Upper airway abnormality
  • - Acute cerebrovascular diseases
  • - Neurologic disorders ( cranial trauma and after neurosurgical
  • - Recent CVA
  • - Moyamoya disease
  • - General anesthesia planned for another procedure

研究者

发起方
Fondation Lenval - Hôpitaux Pédiatriques de Nice CHULENVA

相似试验